The importance of innovators working with third party design firms to get novel medical technologies to market

GCMI and T3 Labs CEO Tiffany Wilson shares insights with Assembly Magazine on what it takes to bring a medical device from concept to commercialization. Developing a new medical technology is not for the faint of heart. It is a daunting, expensive, arduous process, but nevertheless, it is highly rewarding. The developmental pathway is enough…

Enlivening innovation and collaboration: highlights and insights from PEDS2040

Pediatrics 2040 (Peds2040) is the annual meeting hosted by the international Society for Pediatric Innovation (iSPI). The conference connects clinical specialists, entrepreneurs, industry leaders and allied healthcare professionals committed to bettering patient outcomes in pediatrics. In attending PEDS2040 GCMI/T3 Labs was given a unique opportunity to be surrounded by the whole of the pediatric innovation…

Energizing medtech development and taking names: GCMI and T3 Labs CEO Tiffany Wilson named one of Inc.’s “Inspiring Women to Watch in 2017”

GCMI and T3 Labs are proud of our CEO Tiffany Wilson and the commitment and fervor she brings to the medical device community. Recently, Tiffany was recognized as one of Inc.’s “17 inspiring women to watch in 2017.” Each woman spotlighted is an exemplar of leadership and tenacity: acting as a driving force for their…

Igniting medtech innovation: How GCMI assists university-based and physician innovators bring new products to market

  GCMI and T3 Labs CEO Tiffany Wilson shares medtech development pathway insights in Medical Product Outsourcing. Bringing a new medical device from concept to cure to commercialization is an intimidating, complex and expensive process which often stifles innovation instead of encouraging it. Yet there remains a tremendous need and viable markets for medtech innovation…

Navigating the medtech approval pathway: lessons learned from physician innovator Dr. Steven Goudy, MD.

Dr. Steven Goudy, MD, is an associate professor and Director of Pediatric Otolaryngology for the Emory School of Medicine. He recently took the time to sit down with our CEO Tiffany Wilson during a webinar highlighting how physician innovators should approach the medtech development and approval pathway to increase the odds of successfully completing the…

Can you really bootstrap a medtech company? The answer is yes.

Innovators seeking to enter the world of medtech face a daunting path from concept to commercialization. Design, engineering, prototyping and preclinical testing to prepare a single FDA regulatory submission are just a few examples of the many hurdles medtech innovators must successfully clear before event attempting to realize any revenue. For John O’Shaughnessy, Founder and…

Tearing down workforce development silos and supporting next-level collaboration for job growth

We have long maintained that the robust elements of Atlanta’s medtech ecosystem are ripe to support new, high-value job creation in Atlanta and throughout the southeastern United States. Through this lens of job creation through innovation, I was honored to be appointed for a second term on the National Advisory Council on Innovation and Entrepreneurship…